Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...
Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful ...
A new daily pill will give people with stubbornly high cholesterol a cheaper, needle-free way to lower their levels.
2-Year U.S. Treasury Note Continuous Contract $103.004-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.680-0.031-0.03% 10-Year U.S. Treasury Note Continuous Contract $109.219-0.047-0.04 ...
The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...
Lipfendra (enlicitide) offers a convenient option for adults who haven’t been able to lower their cholesterol sufficiently with statins. The U.S. Food and Drug Administration (FDA) approved Lipfendra ...
D CEO’s signature special publication, the Dallas 500, features profiles of the most influential North Texas executives in more than 50 industry categories. The 2026 book, our 11th edition, includes ...
IT procurement continues its rapid shift to a services-led model in the channel. Once again we present the annual CRN MSP 500, the comprehensive list of managed service providers that are leading the ...
Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Wall St Week Ahead Alphabet, Intel results in focus for AI trade as US earnings rev up U.S. corporate earnings season gathers steam in the coming week as Alphabet and Intel are set to offer updates ...